Published in Virology on April 01, 1990
Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J Virol (1991) 3.79
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol (2000) 3.26
Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J Virol (1990) 3.18
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol (1993) 2.64
Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J Virol (2004) 2.06
The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J Virol (1998) 2.05
Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J Virol (1996) 2.03
The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. J Virol (1997) 1.87
Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J Virol (2007) 1.40
Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. J Infect Dis (2011) 1.25
Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J Virol (1993) 1.22
An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. J Virol (1992) 1.17
Identification of second-site mutations that enhance release and spread of vaccinia virus. J Virol (2002) 1.16
Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J Virol (2006) 1.12
Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. J Virol (2008) 1.07
Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex. J Virol (2008) 1.06
Characterization of the vaccinia virus A35R protein and its role in virulence. J Virol (2006) 0.89
Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH. J Virol (2012) 0.84
A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes. J Virol (2014) 0.84
The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins. J Gen Virol (2011) 0.82
Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex. Virol J (2009) 0.79
The pox in the North American backyard: Volepox virus pathogenesis in California mice (Peromyscus californicus). PLoS One (2012) 0.78
Detection of North American orthopoxviruses by real time-PCR. Virol J (2011) 0.78
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell (1988) 3.92
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology (1971) 3.57
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology (1986) 2.49
Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology (1971) 2.06
Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J Virol (1990) 1.89
Neutralizing epitope on penetration protein of vaccinia virus. Virology (1996) 1.75
N-terminal amino acid sequences of vaccinia virus structural proteins. Virology (1994) 1.71
Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis. J Craniofac Surg (2001) 1.47
Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules. Virology (1981) 1.39
Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol (1991) 1.39
Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements. J Virol (1984) 1.38
Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope. Cell (1983) 1.36
Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus. J Gen Virol (1988) 1.31
On the molecular organization, diversity and functions of desmosomal proteins. Ciba Found Symp (1987) 1.31
Functional comparison of transactivation by human retrovirus rev and rex genes. J Virol (1990) 1.27
Characterization of vaccinia polypeptides. Virology (1981) 1.26
Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J Gen Virol (1992) 1.22
Development of heat-stable recombinant rinderpest vaccine. Arch Virol (1989) 1.22
Adsorption and penetration of the trypsinized vaccinia virion. Virology (1980) 1.22
Isolation of the non-glycosylated proteins of desmosomes and immunolocalization of a third plaque protein: desmoplakin III. Proc Natl Acad Sci U S A (1985) 1.17
Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease. J Virol (1988) 1.14
Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1. J Virol (1998) 1.13
Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic [correction of T cell-tropic] HIV-1 by three different monoclonal antibodies. J Immunol (1998) 1.12
Identification of a vaccinia virus penetration protein. Virology (1994) 1.11
Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol (1992) 1.10
Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Virology (2001) 1.09
Simple deep hypothermia for open-heart surgery. J Cardiovasc Surg (Torino) (1979) 1.08
CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry. J Exp Med (1997) 1.07
Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus. J Gen Virol (1991) 1.06
Epitope mosaic on the surface proteins of orthopoxviruses. Virology (1988) 1.05
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. J Virol (1999) 1.04
Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen. Int J Cancer (1991) 1.04
Unit Complex of vaccinia polypeptides linked by disulfide bridges. Virology (1981) 1.02
Changes in ocular astigmatism over the whole range of accommodation. Optom Vis Sci (1991) 1.01
Proteolytic activation of vaccinia virus for the penetration phase of infection. Virology (1982) 1.01
Vaccinia-specific hemagglutinin. Virology (1977) 1.01
Biogenesis of vaccinia: molecular basis for the hemagglutination-negative phenotype of the IHD-W strain. Virology (1982) 1.01
Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J Virol (1994) 1.00
Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J Neuroimmunol (1995) 0.99
Modification of vaccinia virus penetration proteins analyzed by monoclonal antibodies. Virology (1987) 0.97
The activation of vaccinia virus infectivity by the transfer of phosphatidylserine from the plasma membrane. Virology (1983) 0.96
The effect of proteolytic enzymes on the infectivity of vaccinia virus. Virology (1982) 0.96
Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions. J Virol (1999) 0.96
Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I). Int J Cancer (1990) 0.95
The function of the vaccinia hemagglutinin in the proteolytic activation of infectivity. Virology (1990) 0.95
Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells. J Virol (2001) 0.94
Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett (1998) 0.93
[Mammalian glycosidases. IV. Characterization of alpha-D-mannosidase, alpha-D-glucosidase and beta-D-galactosidase and other various glycosidase activities in organs of rabbits and cats]. Seikagaku (1970) 0.92
Mechanism of virus occlusion into A-type inclusion during poxvirus infection. Virology (1977) 0.91
Variants of vaccinia virus hemagglutinin altered in intracellular transport. Mol Cell Biol (1986) 0.89
Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells. J Immunol (1990) 0.89
Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia (1994) 0.88
[Mammalian glycosidases. 2. Ph-dependence and heat tolerance of alpha-mannosidase alpha-glucosidase and alpha-galactosidase activities of the extracts of the various organs of rats and rabbits]. Seikagaku (1969) 0.87
Reversible inactivation and reactivation of vaccinia virus by manipulation of viral lipid composition. Virology (1985) 0.87
Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region. Virology (2000) 0.87
Studies on the nature of Marchal bodies (A-type inclusion) during ectromelia virus infection. Virology (1966) 0.87
Angiotensin II-induced myocardial damage with a special reference to low cardiac output syndrome. Jpn Heart J (1983) 0.87
Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene. J Gen Virol (1997) 0.87
Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens. J Immunol (1989) 0.87
Activation of oncogenic transcription factor AP-1 in T cells infected with human T cell leukemia virus type 1. AIDS Res Hum Retroviruses (2000) 0.86
In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn J Cancer Res (1995) 0.86
Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses. J Virol (1991) 0.85
Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5 kDa protein, and hemagglutinin gene promoters support high levels of expression. Arch Virol (1994) 0.84
Positive symptoms and duration of illness predict functional laterality and attention modulation in schizophrenia. Acta Psychiatr Scand (2006) 0.84
Vaccinia virus hemagglutinin. Subcell Biochem (1989) 0.84
The relationship between poxvirus and A-type inclusion body during double infection. Virology (1968) 0.83
Characterization of antibody and cytotoxic T lymphocyte responses to human influenza virus H3 haemagglutinin expressed from the haemagglutinin locus of vaccinia virus. J Gen Virol (1990) 0.83
Backward-masking deficit in adolescents with schizophrenic disorders or attention deficit hyperactivity disorder. Am J Psychiatry (1996) 0.82
An antigenic structure of the trans-activator protein encoded by human T-cell leukemia virus type-I (HTLV-I), as defined by a panel of monoclonal antibodies. AIDS Res Hum Retroviruses (1992) 0.82
Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I. Int J Cancer (1995) 0.81
Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. J Clin Invest (1994) 0.81
Two distinct pathways for intronless mRNA expression: one related, the other unrelated to human immunodeficiency virus Rev and human T cell leukemia virus type I Rex functions. Biol Signals (1997) 0.81
Ultrastructural and biochemical identification of Con A receptors in the desmosome. J Cell Biochem (1982) 0.80
Characterization of metal ion-implanted titanium oxide photocatalysts operating under visible light irradiation. J Synchrotron Radiat (1999) 0.80
Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system. J Immunol (1991) 0.80
Some factors which influence prognosis after surgery for advanced gastric cancer. Ann Surg (1968) 0.80
Target antigen of vaccinia-infected cells recognized by virus-specific cytotoxic T lymphocytes. Microbiol Immunol (1981) 0.79
Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus. Vaccine (1988) 0.79
No vigilance deficit found in either young schizophrenic or ADHD subjects. Scand J Psychol (1998) 0.79
Biological and immunological characterization of influenza virus haemagglutinin expressed from the haemagglutinin locus of vaccinia virus. J Gen Virol (1990) 0.78
A morphological study in germfree mice (Salmonella infection). Exp Pathol (Jena) (1979) 0.78
Demonstration of desmosomal antigens by electron microscopy using cryofixed and cryosubstituted skin with silver-enhanced gold probe. J Histochem Cytochem (1994) 0.78
Toxic haloperidol reactions with observation of serum haloperidol concentration in two children. Dev Pharmacol Ther (1982) 0.78
Biogenesis of poxviruses: relationship between a translation complex and formation of A-type inclusions. Virology (1973) 0.78
Interleukin-2-dependent but not independent T-cell lines infected with human T-cell leukemia virus type 1 selectively express CD45RO, a marker for persistent infection in vivo. Virus Genes (2001) 0.78
Inhibitory effect of alpha-(1 leads to 6)-heterogalactan on oocyte maturation of starfish induced by 1-methyladenine. Nature (1976) 0.77